These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33797846)

  • 1. AMYQ: An index to standardize quantitative amyloid load across PET tracers.
    Pegueroles J; Montal V; Bejanin A; Vilaplana E; Aranha M; Santos-Santos MA; Alcolea D; Carrió I; Camacho V; Blesa R; Lleó A; Fortea J; ;
    Alzheimers Dement; 2021 Sep; 17(9):1499-1508. PubMed ID: 33797846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AmyloidPETNet: Classification of Amyloid Positivity in Brain PET Imaging Using End-to-End Deep Learning.
    Fan S; Ponisio MR; Xiao P; Ha SM; Chakrabarty S; Lee JJ; Flores S; LaMontagne P; Gordon B; Raji CA; Marcus DS; Nazeri A; Ances BM; Bateman RJ; Morris JC; Benzinger TLS; Sotiras A;
    Radiology; 2024 Jun; 311(3):e231442. PubMed ID: 38860897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing the centiloid transformation for
    Bourgeat P; Doré V; Fripp J; Ames D; Masters CL; Salvado O; Villemagne VL; Rowe CC;
    Neuroimage; 2018 Dec; 183():387-393. PubMed ID: 30130643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers.
    Salvadó G; Molinuevo JL; Brugulat-Serrat A; Falcon C; Grau-Rivera O; Suárez-Calvet M; Pavia J; Niñerola-Baizán A; Perissinotti A; Lomeña F; Minguillon C; Fauria K; Zetterberg H; Blennow K; Gispert JD;
    Alzheimers Res Ther; 2019 Mar; 11(1):27. PubMed ID: 30902090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3.
    Bourgeat P; Doré V; Burnham SC; Benzinger T; Tosun D; Li S; Goyal M; LaMontagne P; Jin L; Rowe CC; Weiner MW; Morris JC; Masters CL; Fripp J; Villemagne VL;
    Neuroimage; 2022 Nov; 262():119527. PubMed ID: 35917917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid brain-dedicated PET images can diagnose Alzheimer's pathology with Centiloid Scale.
    Gandia-Ferrero MT; Torres-Espallardo I; Martínez-Sanchis B; Muñoz E; Morera-Ballester C; Sopena-Novales P; Álvarez-Sánchez L; Baquero-Toledo M; Martí-Bonmatí L
    Phys Med; 2024 May; 121():103345. PubMed ID: 38581963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.
    Klunk WE; Koeppe RA; Price JC; Benzinger TL; Devous MD; Jagust WJ; Johnson KA; Mathis CA; Minhas D; Pontecorvo MJ; Rowe CC; Skovronsky DM; Mintun MA
    Alzheimers Dement; 2015 Jan; 11(1):1-15.e1-4. PubMed ID: 25443857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multisite study of the relationships between antemortem [
    La Joie R; Ayakta N; Seeley WW; Borys E; Boxer AL; DeCarli C; Doré V; Grinberg LT; Huang E; Hwang JH; Ikonomovic MD; Jack C; Jagust WJ; Jin LW; Klunk WE; Kofler J; Lesman-Segev OH; Lockhart SN; Lowe VJ; Masters CL; Mathis CA; McLean CL; Miller BL; Mungas D; O'Neil JP; Olichney JM; Parisi JE; Petersen RC; Rosen HJ; Rowe CC; Spina S; Vemuri P; Villemagne VL; Murray ME; Rabinovici GD
    Alzheimers Dement; 2019 Feb; 15(2):205-216. PubMed ID: 30347188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of
    Reinartz M; Luckett ES; Schaeverbeke J; De Meyer S; Adamczuk K; Thal DR; Van Laere K; Dupont P; Vandenberghe R
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3772-3786. PubMed ID: 35522322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease.
    Amadoru S; Doré V; McLean CA; Hinton F; Shepherd CE; Halliday GM; Leyton CE; Yates PA; Hodges JR; Masters CL; Villemagne VL; Rowe CC
    Alzheimers Res Ther; 2020 Mar; 12(1):22. PubMed ID: 32131891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Software development for quantitative analysis of brain amyloid PET.
    Matsuda H; Yamao T
    Brain Behav; 2022 Mar; 12(3):e2499. PubMed ID: 35134278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale.
    Rowe CC; Jones G; Doré V; Pejoska S; Margison L; Mulligan RS; Chan JG; Young K; Villemagne VL
    J Nucl Med; 2016 Aug; 57(8):1233-7. PubMed ID: 26912446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods.
    Jovalekic A; Roé-Vellvé N; Koglin N; Quintana ML; Nelson A; Diemling M; Lilja J; Gómez-González JP; Doré V; Bourgeat P; Whittington A; Gunn R; Stephens AW; Bullich S
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3276-3289. PubMed ID: 37300571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid PET quantification using low-dose CT-guided anatomic standardization.
    Matsuda H; Yamao T; Shakado M; Shigemoto Y; Okita K; Sato N
    EJNMMI Res; 2021 Dec; 11(1):125. PubMed ID: 34905145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
    Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
    JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Accuracy of Amyloid PET Quantification with Adaptive Template-Based Anatomic Standardization.
    Tsubaki Y; Kitamura T; Shimokawa N; Akamatsu G; Sasaki M;
    J Nucl Med Technol; 2021 Sep; 49(3):256-261. PubMed ID: 33820861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid- positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Wang Y; Lou F; Li Y; Liu F; Wang Y; Cai L; Gordon ML; Zhang Y; Zhang N
    Curr Alzheimer Res; 2021; 18(6):523-532. PubMed ID: 34598664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and acceptance of simultaneous amyloid PET/MRI.
    Schütz L; Lobsien D; Fritzsch D; Tiepolt S; Werner P; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Rullmann M; Sattler B; Patt M; Gertz HJ; Villringer A; Claßen J; Hoffmann KT; Sabri O; Barthel H
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2236-2243. PubMed ID: 27435367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data.
    Lundqvist R; Lilja J; Thomas BA; Lötjönen J; Villemagne VL; Rowe CC; Thurfjell L
    J Nucl Med; 2013 Aug; 54(8):1472-8. PubMed ID: 23740104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.